Label: STRONGID 48- pyrantel tartrate granule

  • Category: OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated August 23, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Strongid® 48
    (pyrantel tartrate)

    Type A Medicated Article

    Equine Anthelmintic

  • Active Drug Ingredient:

    Pyrantel tartrate.........................................10.6% (48 g/lb)

  • Indications for Use:

    For the prevention of Strongylus vulgaris larval infestation in horses.

    For control of the following parasites in horses:
    Large Strongyles (adults): S. vulgaris, S. edentatus
    Small Strongyles (adults and fourth-stage larvae): Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp., Poteriostomum spp., Triodontophorus spp.
    Pinworms (adults and fourth-stage larvae): Oxyuris equi
    Ascarids (adults and fourth-stage larvae): Parascaris equorum

  • CAUTION:

    CAUTION: For use in manufacturing of equine feeds only.

    CAUTION: Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety.

    Precautions such as the following should be considered: dust masks or respirators and protective clothing should be worn; dust-arresting equipment and adequate ventilation should be utilized; personal hygiene should be observed; wash before eating or leaving a work site; be alert for signs of allergic reactions—seek prompt medical treatment if such reactions are suspected.

  • Storage

    STORE IN A DRY, COOL PLACE
    SEE BACK PANEL FOR FURTHER USE DIRECTIONS

  • SPL UNCLASSIFIED SECTION

    Net Weight: 50 lb (22.6 kg)

    Approved by FDA under NADA  # 140-819

    51047200

  • Mixing and Use Directions

    Strongid is to be administered on a continuous basis either as a top-dress or mixed in the horse’s daily grain ration at the rate of 1.2 mg/lb (2.64 mg/kg) of body weight daily. The duration of administration is for the period during which the horse is at risk of exposure to internal parasites.

    Foals may be treated at such time when consistent intake of grain mix is occurring. This is generally between 2 and 3 months of age. 

    Strongid may be used in mares at any stage of pregnancy or lactation. Stallion fertility is not affected by the use of Strongid.

    Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

    Typical Mixing Directions to Deliver 1.2 mg/lb (2.64 mg/kg)

    lb of Medicated Grain Mix per 100 lb of Body Weightlb of Strongid 48lb of Nonmedicated FeedResulting Concentration (g/ton)
     2.002.51997.5120
    1.53.31996.7160
    0.5010.01990.0480
    0.2025.01975.01200

    lb of Medicated Top-Dress per 100 lb of Body Weightlb of Strongid 48lb of Nonmedicated FeedResulting Concentration (g/ton)
    0.04125.01875.06000
    0.025200.01800.09600
    0.02250.01750.012000
    0.0125400.01600.019200
  • WARNING

    Do not use in horses intended for human consumption.

  • OTHER WARNINGS

    Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

  • CAUTION

    Consult your veterinarian before using in severely debilitated animals and for assistance in the diagnosis, treatment, and control of parasitism. Do not mix in feeds containing bentonite.

  • SPL UNCLASSIFIED SECTION

    51047200

    Zoetis

    Distributed by:
    Zoetis Inc.
    Kalamazoo, MI 49007
    Product of Mexico

  • PRINCIPAL DISPLAY PANEL - 50lb bag label

    50lb bag label
  • INGREDIENTS AND APPEARANCE
    STRONGID  48
    pyrantel tartrate granule
    Product Information
    Product TypeOTC TYPE A MEDICATED ARTICLE ANIMAL DRUGItem Code (Source)NDC:54771-0459
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PYRANTEL TARTRATE (UNII: SC82VF0480) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL TARTRATE105.8 g  in 1 kg
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54771-0459-122.6 kg in 1 BAG
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA14081908/24/2018
    Labeler - Zoetis Inc. (828851555)